MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is rolling out a novel system that uses artificial intelligence to identify drug and alcohol impairment through voice analysis, with an initial focus on the South American mining sector. The company, which has spent years researching intoxication detection, has developed what it calls the first voice-based AI system in the world capable of spotting signs of impairment within seconds.
Instead of relying on traditional biological testing methods such as breathalyzers or laboratory samples, MindBio’s technology analyzes acoustic patterns in speech to estimate intoxication levels. The platform is being developed for enterprise use, with the company currently preparing a hardware kiosk system that can screen workers as they enter industrial facilities, according to an article discussing the technology.
The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of environments including the mining industry, aviation, construction, and law enforcement.
The initial deployment in the South American mining sector highlights the critical need for safety monitoring in remote operations where heavy machinery is used. The ability to quickly and non-invasively screen workers could significantly reduce accidents caused by impairment. This technology could also have broader implications for workplace safety across various industries, offering a more efficient and potentially less intrusive alternative to current methods.
For more details, the full article can be viewed at https://ibn.fm/ZPBcc. The latest news and updates relating to MBQIF are available in the company’s newsroom at https://ibn.fm/MBQIF.
